back to list

ZIMENT GROUP ANNOUNCES NEW RESPONSIBILITES FOR JOHN TAPPER

NEW YORK, December 13, 2004 – The Ziment Group, a consortium of leading healthcare and pharmaceutical market research companies headquartered in New York, announced today that John Tapper, PhD., has added the title of Chief Strategy Officer of The Ziment Group to his responsibilities within the group’s full service division called Ziment.

“This additional title is to acknowledge the excellent work that John has done since he joined our company,” said Howard Ziment, Chief Executive Officer of The Ziment Group. “It also recognizes his responsibility for helping set strategic direction for the group, as well as for product development for our new imap division.”

imap Research, a Ziment Group company, is a newly formed division which focuses on conducting multi-client studies for healthcare and pharmaceutical clientele.

“I look forward to creating new approaches that bring value to our client’s business,” said Tapper. “imap will apply paradigm shifting innovations to multi-client research constructs in much the same way that Ziment has done in custom market research. This is exciting for both the Ziment Group and our clients.”

About The Ziment Group:
The Ziment Group consists of Ziment, a full service consultancy offering custom marketing research for the healthcare and pharmaceutical industries worldwide; WebSurveyResearch which houses the largest dedicated panel of physicians with which to conduct marketing research through the internet; and imap Research, a division dedicated to conducting multi-client research.

The Ziment Group is the global healthcare research brand for The Kantar Group, the Information and Consultancy Division of WPP, plc. For more information on Ziment, go to www.ziment.com.

^ Top ^